Over the last 12 months, Werewolf Therapeutics insiders reported no purchases and 14 sales totaling $882K across SEC Form 4 filings. 79% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | EVNIN LUKED | ▼ Sale | 143,199 | $0.31 | $45K | -100% | plan · 2 tranches · indirect |
| Jun 29, 2026 | EVNIN LUKED | ▼ Sale | 157,084 | $0.3 | $47K | -52.3% | plan · indirect |
| Jun 17, 2026 | RA CAPITAL MANAGEMENT, L.P.10% | ▼ Sale | 416,911 | $0.35 | $146K | -57.9% | 2 tranches · indirect |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P.10% | ▼ Sale | 448,836 | $0.39 | $174K | -57.5% | 6 tranches · indirect |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P.10% | ▼ Sale | 678,226 | $0.37 | $254K | -65.2% | 6 tranches · indirect |
| Jun 9, 2026 | EVNIN LUKED | ▼ Sale | 76,928 | $0.37 | $28K | -20.4% | plan · indirect |
| Jun 8, 2026 | EVNIN LUKED | ▼ Sale | 105,565 | $0.41 | $43K | -21.9% | plan · 3 tranches · indirect |
| Jun 3, 2026 | EVNIN LUKED | ▼ Sale | 29,749 | $0.42 | $12K | -5.8% | plan · indirect |
| Jun 2, 2026 | EVNIN LUKED | ▼ Sale | 29,595 | $0.45 | $13K | -5.5% | plan · indirect |
| Jun 1, 2026 | EVNIN LUKED | ▼ Sale | 80,459 | $0.47 | $38K | -12.9% | plan · indirect |
| May 29, 2026 | EVNIN LUKED | ▼ Sale | 32,556 | $0.45 | $15K | -5% | plan · indirect |
| May 28, 2026 | EVNIN LUKED | ▼ Sale | 27,698 | $0.46 | $13K | -4.1% | plan · indirect |
| May 27, 2026 | EVNIN LUKED | ▼ Sale | 80,852 | $0.48 | $39K | -10.6% | plan · indirect |
| May 21, 2026 | EVNIN LUKED | ▼ Sale | 36,387 | $0.42 | $15K | -3.8% | plan · indirect |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $HOWL feed.